Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 20199 results available
- November 20194 results available
- October 20196 results available
- September 20195 results available
- August 20191 results available
- July 20195 results available
- June 20197 results available
- May 20195 results available
- April 20196 results available
- March 20194 results available
- February 20192 results available
- January 20193 results available
Displaying 16 - 30 of 57 items.
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
AlertHealth professional risk communication | 2019-10-15
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove from their carrier tubes
AlertPublic advisory | 2019-10-11
Unauthorized Nabota botulinum toxin may pose serious health risks
AlertPublic advisory | 2019-09-30
Unauthorized products may pose serious health risks (August 12, 2019 to September 18, 2019)
AlertPublic advisory | 2019-09-18
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
AlertInformation update | 2019-09-17
Health Canada assessing NDMA in ranitidine
AlertInformation update | 2019-09-13
Health Canada seized unauthorized Bielenda Dr. Medica anti-acne products because they may pose serious health risks
AlertPublic advisory | 2019-09-03
Dozens of health products seized from Aphrodite Aesthetic Clinic in North York, Ontario, may pose serious health risks
AlertPublic advisory | 2019-08-15
Unauthorized products may pose serious health risks (June 11, 2019 to July 26, 2019)
AlertPublic advisory | 2019-07-26
Three unauthorized eye solutions seized from a Glorious Cosmetics store in Edmonton, Alberta, may pose serious health risks
AlertPublic advisory | 2019-07-24
Tacrolimus and the Risk of Graft Rejection due to Medication Errors: Inadvertent Switching between Different Oral Formulations
AlertHealth professional risk communication | 2019-07-22
Pfizer Canada is reporting a shortage of EpiPen (0.3 mg) auto-injectors and taking precautions to minimize impact on Canadians
AlertInformation update | 2019-07-19
Nutrabolics Inc. voluntarily recalls unauthorized "Blackout" sleep-aid, which may pose serious health risks
AlertPublic advisory | 2019-07-11